Ubs Group Ag Iridex Corp Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Iridex Corp stock. As of the latest transaction made, Ubs Group Ag holds 1,502 shares of IRIX stock, worth $1,997. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,502

Previous 12,309 87.8%

Holding current value

$1,997

Previous $20,000 95.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$0.8 - $1.78 $8,645 - $19,236	-10,807 Reduced 87.8%	1,502 $1,000
Q4 2024 Feb 14, 2025	SELL	$1.39 - $1.93 $4,984 - $6,920	-3,586 Reduced 22.56%	12,309 $20,000
Q3 2024 Nov 14, 2024	BUY	$1.75 - $2.15 $10,939 - $13,439	6,251 Added 64.82%	15,895 $27,000
Q2 2024 Aug 13, 2024	BUY	$1.97 - $3.53 $18,626 - $33,376	9,455 Added 5002.65%	9,644 $20,000
Q1 2024 May 13, 2024	SELL	$2.35 - $3.1 $15,514 - $20,466	-6,602 Reduced 97.22%	189 $0
Q4 2023 Feb 09, 2024	BUY	$1.9 - $3.28 $12,902 - $22,274	6,791 New	6,791 $19,000
Q1 2023 May 12, 2023	BUY	$2.0 - $2.46 $5,632 - $6,927	2,816 New	2,816 $5,000
Q2 2022 Aug 10, 2022	SELL	$2.48 - $4.66 $7,132 - $13,402	-2,876 Reduced 65.72%	1,500 $4,000
Q1 2022 May 16, 2022	BUY	$3.99 - $6.42 $11,475 - $18,463	2,876 Added 191.73%	4,376 $20,000
Q3 2021 Nov 15, 2021	SELL	$6.29 - $7.98 $13,768 - $17,468	-2,189 Reduced 59.34%	1,500 $11,000
Q2 2021 Aug 13, 2021	BUY	$6.67 - $9.2 $11,719 - $16,164	1,757 Added 90.94%	3,689 $26,000
Q1 2021 May 12, 2021	SELL	$2.18 - $7.71 $35,063 - $124,007	-16,084 Reduced 89.28%	1,932 $13,000
Q4 2020 Feb 11, 2021	BUY	$1.62 - $2.91 $26,755 - $48,061	16,516 Added 1101.07%	18,016 $45,000
Q2 2020 Jul 31, 2020	SELL	$1.4 - $2.58 $2,310 - $4,257	-1,650 Reduced 52.38%	1,500 $3,000
Q1 2020 May 01, 2020	SELL	$1.4 - $3.64 $6,752 - $17,555	-4,823 Reduced 60.49%	3,150 $5,000
Q4 2019 Feb 14, 2020	BUY	$1.77 - $2.57 $8,536 - $12,395	4,823 Added 153.11%	7,973 $18,000
Q2 2019 Aug 14, 2019	SELL	$4.39 - $5.61 $11,291 - $14,428	-2,572 Reduced 44.95%	3,150 $14,000
Q1 2019 May 14, 2019	SELL	$4.14 - $5.18 $3,109 - $3,890	-751 Reduced 11.6%	5,722 $26,000
Q4 2018 Feb 14, 2019	BUY	$3.85 - $6.3 $862 - $1,411	224 Added 3.58%	6,473 $31,000
Q3 2018 Nov 14, 2018	BUY	$6.0 - $9.15 $27,090 - $41,312	4,515 Added 260.38%	6,249 $40,000
Q2 2018 Aug 14, 2018	SELL	$5.33 - $7.24 $19,230 - $26,121	-3,608 Reduced 67.54%	1,734 $12,000
Q1 2018 May 15, 2018	BUY	$5.72 - $8.28 $21,118 - $30,569	3,692 Added 223.76%	5,342 $30,000
Q3 2017 Nov 14, 2017	SELL	$8.19 - $10.25 $15,389 - $19,259	-1,879 Reduced 53.24%	1,650 $15,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,512 Added 74.96%	3,529 $35,000
Q1 2017 Nov 14, 2017	BUY	N/A	2,017	2,017 $24,000

Others Institutions Holding IRIX

# of Institutions

Shares Held

3.12M

Call Options Held

Put Options Held

View Full List

About IRIDEX CORP

Ticker IRIX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 15,985,600
Market Cap $21.3M
Description
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...

More about IRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account